ATAI Life Sciences
ATAI
ATAI
116 hedge funds and large institutions have $66.6M invested in ATAI Life Sciences in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 15 closing their positions.
Holders
116
Holders Change
+15
Holders Change %
+14.85%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
37
Reduced
17
Closed
15
Calls
$3.17M
Puts
$1.05M
Net Calls
+$2.12M
Net Calls Change
+$1.95M
Top Buyers
| 1 |
1
Cerity Partners
New York
|
$3.58M |
| 2 |
SCM
2
Suvretta Capital Management
New York
|
$4.36M |
| 3 |
SSA
3
Schonfeld Strategic Advisors
New York
|
$1.26M |
| 4 |
4
BlackRock
New York
|
$5.11M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$1.19M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
VOYA Investment Management
Atlanta,
Georgia
| – | -$82.8K | -25,006 | Closed |
|
|
WCP
127
Welch Capital Partners
Harrison,
New York
| – | -$79K | -23,998 | Closed |
|
128
Ensign Peak Advisors
Salt Lake City,
Utah
| – | -$50K | -15,030 | Closed |
|
129
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$37K | -11,086 | Closed |
|
130
Wells Fargo
San Francisco,
California
| – | -$13K | -4,000 | Closed |
|
|
EBA
131
Eagle Bay Advisors
New York
| – | -$4K | -1,300 | Closed |
|